Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we will assume that you are happy to receive all cookies and you will not see this message again. Click 'Find out more' for information on how to change your cookie settings.

Today’s Research Excellence Framework (REF 2014) results confirm the University of Oxford’s world leading position in medical sciences research.

The Department of Physiology, Anatomy & Genetics formed part of the University’s REF return under the Biological Sciences unit of assessment and we are delighted that out of the 44 institutions making a return under this unit of assessment, Oxford returned the greatest volume of world leading (4*) ranked activity.

Read more on the University's website and on the Medical Sciences Division's website

Similar stories

Reducing fat in the diabetic heart could improve recovery from heart attack

New research from the Heather Group has shown that in type 2 diabetes an overload of lipids reduces the heart’s ability to generate energy during a heart attack, decreasing chances of recovery.

The brain’s one-sided teaching signals

A new study by the Lak group reveals a novel facet of dopamine signalling during visual decision making.

The prime of Professor Dame Kay Davies

Professor Dame Kay Davies, Professor of Genetics, first woman appointed Dr Lee's Professor of Anatomy at Oxford, first woman to become Head of Department for DPAG, University-wide champion of equality, and award winning scientist known for her work on Duchenne muscular dystrophy, has 'retired' after a lifetime's research, but remains Professor Emeritus at DPAG.

Fellowship awarded to Huriye Atilgan to enhance our understanding of value-based decision-making

Congratulations are in order for Postdoctoral Research Scientist Dr Huriye Atilgan who has been awarded a prestigious Sir Henry Wellcome Postdoctoral Fellowship funded by the Wellcome Trust.

The future of stroke treatment

A team of international collaborators including DPAG's Dr Mootaz Salman has been researching a promising new therapeutic for the treatment of strokes and other brain injuries.